Clinical Trial

Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC

Study acronym: COLOPan
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The ColoPan study evaluates the scientific validity, reproducibility, and predictive performance of the Personalised Functional Profiling (PFP) platform in colorectal cancer and pancreatic ductal adenocarcinoma patients. It combines genomic sequencing with in vitro functional drug testing using patient-derived spheroids/organoids.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-24.
Trial Details
NCT Number NCT07500259
Lead Sponsor Luxembourg Institute of Health
Collaborators: Hopitaux Robert Schuman
Conditions Colorectal Cancer, PDAC - Pancreatic Ductal Adenocarcinoma
Enrollment 188 participants
Start Date 2026-07-01
Primary Completion 2029-09-30 (estimated)
Study Completion 2034-11-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-23